This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: TICAGRELOR MONOTHERAPY AFTER 1-MONTH DUAL ANTIPLATELET THERAPY VERSUS STANDARD DUAL ANTIPLATELET THERAPY FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS, Journal of the American College of Cardiology, April 2025, Elsevier,
DOI: 10.1016/s0735-1097(25)01430-5.
You can read the full text:
The following have contributed to this page
